Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus

MLA

E. De Clercq, et al. “Identification of Novel Thiocarboxanilide Derivatives That Suppress a Variety of Drug-Resistant Mutant Human Immunodeficiency Virus Type 1 Strains at a Potency Similar to That for Wild-Type Virus.” Antimicrobial Agents and Chemotherapy, vol. 40, June 1996, pp. 1454–66. EBSCOhost, https://doi.org/10.1128/aac.40.6.1454.

APA

E. De Clercq, E M Osika, D C Dao, W G Brouwer, & Jan Balzarini. (1996). Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus. Antimicrobial Agents and Chemotherapy, 40, 1454–1466. https://doi.org/10.1128/aac.40.6.1454

Chicago

E. De Clercq, E M Osika, D C Dao, W G Brouwer, and Jan Balzarini. 1996. “Identification of Novel Thiocarboxanilide Derivatives That Suppress a Variety of Drug-Resistant Mutant Human Immunodeficiency Virus Type 1 Strains at a Potency Similar to That for Wild-Type Virus.” Antimicrobial Agents and Chemotherapy 40 (June): 1454–66. doi:10.1128/aac.40.6.1454.